Announcement on the Obtaining of the Drug Registration Certificate for the New Indication of the Collaborative Product Masiloxavir Tablets

About this update from Hubei Jumpcan Pharmaceutical Co., Ltd Class A

Announcement on the Obtaining of the Drug Registration Certificate for the New Indication of the Collaborative Product Masiloxavir Tablets The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hubei Jumpcan Pharmaceutical Co., Ltd Class A